ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 165 filers reported holding ANIKA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,044 | -96.7% | 56 | -95.3% | 0.00% | -100.0% |
| Q2 2023 | $31,280 | -6.4% | 1,204 | +3.4% | 0.00% | 0.0% |
| Q1 2023 | $33,431 | -2.0% | 1,164 | +1.0% | 0.00% | -25.0% |
| Q4 2022 | $34,099 | +31.2% | 1,152 | +7.5% | 0.00% | +33.3% |
| Q3 2022 | $26,000 | +2500.0% | 1,072 | +3596.6% | 0.00% | – |
| Q2 2022 | $1,000 | – | 29 | +45.0% | 0.00% | – |
| Q3 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 20 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | 0.0% | 20 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | – | 20 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q4 2016 | $0 | – | 20 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 20 | 0.0% | 0.00% | -100.0% |
| Q2 2016 | $1,000 | – | 20 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 20 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 490,331 | $21,928,000 | 10.27% |
| CAPITAL MANAGEMENT CORP /VA | 211,660 | $9,465,000 | 3.66% |
| AMI ASSET MANAGEMENT CORP | 336,791 | $15,061,000 | 1.03% |
| Baltimore-Washington Financial Advisors, Inc. | 68,785 | $3,076,000 | 0.93% |
| Portolan Capital Management | 130,939 | $5,856,000 | 0.78% |
| Kalos Management, Inc. | 19,254 | $861,000 | 0.72% |
| DIKER MANAGEMENT LLC | 32,965 | $1,474,000 | 0.56% |
| THOMPSON SIEGEL & WALMSLEY LLC | 1,526,244 | $68,253,000 | 0.56% |
| NEW AMSTERDAM PARTNERS LLC/NY | 108,260 | $4,841,000 | 0.51% |
| Boston Trust Walden Corp | 493,780 | $22,082,000 | 0.38% |